Yuan‑zhi‑san inhibits tau protein aggregation in an Aβ1‑40‑induced Alzheimer's disease rat model via the ubiquitin‑proteasome system. 2021

Bin Li, and Pei-Jun Xie, and Yan-Wei Hao, and Yu Guo, and Jun-Rong Yu, and Dao-Yin Gong, and Jing Guo, and Jin-Hao Zeng, and Yi Zhang
Geriatric Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610072, P.R. China.

Yuan‑zhi‑san (YZS) is a classic type of Traditional Chinese Medicine, which has been reported to aid in the treatment of Alzheimer's disease (AD). The present study aimed to investigate the effects of YZS on tau protein aggregation, a hallmark of AD pathology, and its possible mechanisms. The results demonstrated that YZS improved learning and memory abilities, and decreased the severity of AD pathology in β‑amyloid (Aβ1‑40)‑induced AD rats. Moreover, YZS administration inhibited the hyperphosphorylation of tau protein at Ser199 and Thr231 sites. Several vital enzymes in the ubiquitin‑proteasome system (UPS), including ubiquitin‑activating enzyme E1a/b, ubiquitin‑conjugating enzyme E2a, carboxyl terminus of Hsc70‑interacting protein, ubiquitin C‑236 terminal hydrolase L1 and 26S proteasome, were all significantly downregulated in AD rats, which indicated an impaired enzymatic cascade in the UPS. In addition, it was identified that YZS treatment partly increased the expression levels of these enzymes in the brains of AD rats. In conclusion, the present results suggested that YZS could effectively suppress the hyperphosphorylation of tau proteins, which may be partially associated with its beneficial role in restoring functionality of the UPS.

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004365 Drugs, Chinese Herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Chinese Herbal Drugs,Plant Extracts, Chinese,Chinese Drugs, Plant,Chinese Plant Extracts,Extracts, Chinese Plant,Herbal Drugs, Chinese
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid
D016875 tau Proteins Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES). tau Protein,Protein, tau,Proteins, tau

Related Publications

Bin Li, and Pei-Jun Xie, and Yan-Wei Hao, and Yu Guo, and Jun-Rong Yu, and Dao-Yin Gong, and Jing Guo, and Jin-Hao Zeng, and Yi Zhang
March 2021, Neurobiology of aging,
Bin Li, and Pei-Jun Xie, and Yan-Wei Hao, and Yu Guo, and Jun-Rong Yu, and Dao-Yin Gong, and Jing Guo, and Jin-Hao Zeng, and Yi Zhang
January 2018, American journal of translational research,
Bin Li, and Pei-Jun Xie, and Yan-Wei Hao, and Yu Guo, and Jun-Rong Yu, and Dao-Yin Gong, and Jing Guo, and Jin-Hao Zeng, and Yi Zhang
April 2008, Journal of cellular and molecular medicine,
Bin Li, and Pei-Jun Xie, and Yan-Wei Hao, and Yu Guo, and Jun-Rong Yu, and Dao-Yin Gong, and Jing Guo, and Jin-Hao Zeng, and Yi Zhang
November 2004, Trends in molecular medicine,
Bin Li, and Pei-Jun Xie, and Yan-Wei Hao, and Yu Guo, and Jun-Rong Yu, and Dao-Yin Gong, and Jing Guo, and Jin-Hao Zeng, and Yi Zhang
December 2004, Progress in neurobiology,
Bin Li, and Pei-Jun Xie, and Yan-Wei Hao, and Yu Guo, and Jun-Rong Yu, and Dao-Yin Gong, and Jing Guo, and Jin-Hao Zeng, and Yi Zhang
April 2024, Brain research,
Bin Li, and Pei-Jun Xie, and Yan-Wei Hao, and Yu Guo, and Jun-Rong Yu, and Dao-Yin Gong, and Jing Guo, and Jin-Hao Zeng, and Yi Zhang
June 2013, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis,
Bin Li, and Pei-Jun Xie, and Yan-Wei Hao, and Yu Guo, and Jun-Rong Yu, and Dao-Yin Gong, and Jing Guo, and Jin-Hao Zeng, and Yi Zhang
March 2012, Molecular pharmaceutics,
Bin Li, and Pei-Jun Xie, and Yan-Wei Hao, and Yu Guo, and Jun-Rong Yu, and Dao-Yin Gong, and Jing Guo, and Jin-Hao Zeng, and Yi Zhang
May 2001, Science (New York, N.Y.),
Bin Li, and Pei-Jun Xie, and Yan-Wei Hao, and Yu Guo, and Jun-Rong Yu, and Dao-Yin Gong, and Jing Guo, and Jin-Hao Zeng, and Yi Zhang
November 2007, BMC biochemistry,
Copied contents to your clipboard!